Work

Lifetime Management for Aortic Stenosis: Strategy and Decision-Making in the Current Era

Year: 2024

Type: review

Abstract: Aortic stenosis, the most common valvular disease in the Western world, has traditionally been treated with surgical aortic valve replacement (SAVR) but is increasingly treated by transcatheter aortic valve replacement (TAVR). Whereas patients older than 65 years are preferably treated with bioprosthetic tissue valves, there is considerable uncertainty in the choice between TAVR and SAVR. We present various considerations for optimizing the lifelong management of patients receiving bioprosthetic valves (SAVR or TAVR). To maximize life expectancy and to minimize cumulative lifetime risk, we suggest decision-making individualized for patient anatomy and overall (current and future) risk.

Source: The Annals of Thoracic Surgery

DOI: 10.1016/j.athoracsur.2024.05.047

Authors: Shmuel Chen, Andrei Pop, Lakshmi Prasad Dasi, Isaac George

Institutions: NewYork–Presbyterian Hospital, Weill Cornell Medical Center, Alexian Brothers Medical Center, Columbia University Irving Medical Center

Language: English

Topic: Cardiac Valve Diseases and Treatments

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,200